Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

FDA Commissioner Gottlieb Grants DQSA Coalition Meeting Request

Wednesday, November 1, 2017   (0 Comments)
Posted by: IACP
Share |
IACP Members: We have some very exciting news! Due to the incredible diligence and hard work of the DQSA Coalition, the  Food & Drug Administration (FDA) Commissioner, Scott Gottlieb, MD, has granted our request for a meeting. Read here Dr. Gottlieb's letter sent to David Pore of Hance Scarborough LLP, IACP's D.C. legislative counsel. 
 
The DQSA Coalition, comprised of more than 30 provider and pharmacy organizations and led by IACP's Executive Vice President Cynthia Blankenship, was created with a primary goal of ensuring the FDA implements the Drug Quality & Security Act as Congress fully intended in order to preserve patient access to vital compounded medications
 
As such, the DQSA Coalition has steadily worked over the past year to communicate its concerns that patients are being prevented critical access to the essential compounded medications upon which they depend. Please click here to view the letter the DQSA Coalition sent last June to the  United States Secretary of Health and Human Services Dr. Thomas E. Price, requesting a meeting to discuss these concerns on behalf of your patients.   
 
We are pleased our efforts have resulted in scheduling a meeting with Dr. Gottlieb and will keep you apprised of all updates. IACP is working hard to preserve your patients' access to life-saving compounded medications!

 

Read more HERE.


Association Management Software Powered by YourMembership  ::  Legal